Tag: Resource pages

  • Vaccination data update, Jan. 3

    Despite the holidays, several more states began reporting vaccination data in the past week. The Centers for Disease Control and Prevention (CDC) also made a huge update: this national dashboard is now posting vaccination counts at the state level.

    Here are the notable updates:

    • I launched a vaccination data page on the CDD site which includes annotations on ten major national sources and every state’s vaccination reporting. I’ll be updating it weekly—the most recent update was yesterday.
    • Five states have started regularly reporting vaccination data since December 27: Alabama, Alaska, Indiana, Mississippi, and Wisconsin. 32 total states are now reporting these data; 15 states are reporting race and ethnicity of vaccinated residents. See more details on the resource page.
    • On December 30, the CDC started reporting state-level vaccination data on its national COVID-19 dashboard. For every state, the CDC is reporting total vaccine doses distributed and total people who have received their first dose. The dashboard also includes national counts—both for the U.S. as a whole and for long-term care facilities. Data are not yet available for download. According to the most recent update (yesterday, January 2), 4.2 million Americans have received their first dose.
    • Drew Armstrong, the Bloomberg reporter who runs the publication’s vaccination dashboard, posted a vaccine data user guide on Twitter. While the Tweet thread primarily describes the methodology and design choices behind Bloomberg’s dashboard, it also provides useful context for vaccination data overall. Two notable details: all vaccination data lag (the CDC’s data lag by about 50 hours, according to Armstrong), and Bloomberg is working on making the underlying data behind their dashboard public.
    • Benjy Renton halted updates for the “Doses Administered” tracker on his Vaccine Allocation Dashboard. As the CDC is now providing standardized state counts—and Renton is a one-person tracking operation—he’s switching to focus on analyzing vaccination trends and accessibility.  
    • Distribution delays: Operation Warp Speed promised that, if the Pfizer and Moderna vaccines received Emergency Use Authorization from the FDA, 20 million Americans would get vaccine doses by the end of 2020. That clearly didn’t happen. What went wrong? To answer that question, I recommend two articles: this STAT News story and this CNN story. Both articles suggest that a lag in data reporting may be one reason why the current vaccination counts look so low. Still, there’s a big difference between 4.2 million and 20 million.
    • Vaccination and the new COVID-19 strain: As the B.1.1.7 coronavirus variant, identified in the U.K., becomes an increasingly ominous threat to America’s COVID-19 containment, vaccination becomes increasingly urgent. Zeynep Tufekci’s latest piece in The Atlantic explains the issue. One piece that stuck out to me: the U.S. doesn’t have good genomic surveillance—or, a system to systematically sequence the virus genomes for people infected with SARS-CoV-2—which makes us less equipped to see where the new strain is actually spreading. As Tufekci puts it: “we are flying without a map.”
    • One dose or two? Scientists and public health leaders have been debating changing our vaccination protocol. Should the U.S. stick to the script, so to speak, and reserve enough vaccine doses that everyone who receives one dose can receive a second in the prescribed time window? Or should we give as many people first doses as we can, accepting that some may not get a second dose for months—or at all? (The U.K. opted for the latter earlier this week.) University of Washington professor Carl Bergstrom has compiled some Twitter threads that explain the debate. Dr. Fauci said on Friday that the U.S. will stick to the official two-dose regimen, but the scientific discourse will likely continue.

    Related posts

    • Sources and updates, November 12
      Sources and updates for the week of November 12 include new vaccination data, a rapid test receiving FDA approval, treatment guidelines, and more.
    • How is the CDC tracking the latest round of COVID-19 vaccines?
      Following the end of the federal public health emergency in May, the CDC has lost its authority to collect vaccination data from all state and local health agencies that keep immunization records. As a result, the CDC is no longer providing comprehensive vaccination numbers on its COVID-19 dashboards. But we still have some information about this year’s vaccination campaign, thanks to continued CDC efforts as well as reporting by other health agencies and research organizations.
    • Sources and updates, October 8
      Sources and updates for the week of October 8 include new papers about booster shot uptake, at-home tests, and Long COVID symptoms.
    • COVID source shout-out: Novavax’s booster is now available
      This week, the FDA authorized Novavax’s updated COVID-19 vaccine. Here’s why some people are excited to get Novavax’s vaccine this fall, as opposed to Pfizer’s or Moderna’s.
  • Your guide to choosing a COVID-19 data source

    Your guide to choosing a COVID-19 data source

    In preparing for this re-launch, I asked a few of my readers what they liked about the COVID-19 Data Dispatch and how it could better serve them. One common answer was that the publication has helped readers navigate the landscape of COVID-19 data sources, and pick the best source for a given story.

    The first two resources pages I’ve produced take this service to the next level.

    First: The Featured Source List is an upgraded version of the Google spreadsheet I’ve been using to keep track of data sources featured in the newsletter since July. You can use the table to search, sort, and filter all 82 featured sources by their names and categories. The little green plus icons toggle expanded views, with more details on every source. Much friendlier than a spreadsheet!  (Though, if you want to see the raw spreadsheet, it’s still accessible here.)

    Second: The Data Source Finder tool tells you exactly where to find the data you need for a given story.  (Or for a Facebook post, or an argument with your friend, and so forth.)  The tool includes detailed annotations on 16 data sources which I consider the primary COVID-19 sources in the U.S.

    Here’s how to use it. You start out by selecting the geographic scale on which you’d like to see data (global, U.S. states, counties, or cities), then choose the type of metric you’re looking for. The tool will return your options, including each dataset’s available metrics, methodologies, update schedule, download links, and more.

    It’s essentially an interactive flowchart, aimed to make it easy to compare and contrast sources for reporters on deadline and students engaged in Twitter debates alike. You can also find the full set of annotations linked on the page.

    While I compiled the annotations, the interactive tool was coded in Twine by my girlfriend, Laura Berry.  Your membership fees will help me buy Laura a nice dinner to thank her for her work.